It is the intent of this EOI to secure competitive proposals from qualified and experienced laboratory service providers for the analysis of samples to determine the chemoprevention efficacy of sulfadoxine-pyrimethamine (SPAQ) when used in seasonal malaria chemoprevention (SMC). The samples were collected or will be collected by Malaria Consortium and partners in countries where Malaria Consortium supports SMC.
